Quantcast
Last updated on April 24, 2014 at 5:50 EDT

Latest Umbilical cord Stories

2011-11-14 13:51:00

In the news release, Cord Blood America Says Nine Month Revenues Up 59 Percent to $4.38 Million, issued 14-Nov-2011 by Cord Blood America, Inc. over PR Newswire, we are advised by the company that the fourth paragraph should read as stated below rather than as originally issued inadvertently. The complete, corrected release follows: Cord Blood America Says Nine Month Revenues Up 59 Percent to $4.38 Million -- Gross Profit Up 91 Percent -- LAS VEGAS, Nov. 14, 2011 /PRNewswire/ --...

2011-11-14 07:39:00

LAS VEGAS, Nov. 14, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced revenues for the nine months ended September 30, 2011 totaled $4.38 million, up 59 percent compared to revenues of $2.75 million in the same period in 2010. Revenues for the third quarter were up...

2011-10-31 04:02:00

LAS VEGAS, Oct. 31, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that since it launched a Referral Rewards Program on July 7, 2011, referral sales have risen from 8 to 21 percent of total sales. The program, announced by CorCell, its domestic brand for...

2011-10-28 06:00:00

The agreement includes a collaborative research initiative, which supports Tissue Regeneration Therapeutics' international leadership in the field of mesenchymal stem cell technology. TORONTO, Oct. 28, 2011 /PRNewswire/ - J. E. Davies, President and CEO of Tissue Regeneration Therapeutics (TRT), announced today an exclusive licensing agreement with PerkinElmer's family cord blood banking business, ViaCord(R), which will now be able to offer families in the US the ability to extract...

2011-10-13 10:25:22

New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks. At least 20 million people survive heart attacks and strokes every year, according to World Health Organization estimates, but many have poor life expectancy and require continual costly clinical care.  The use of patient´s own stem cells may repair heart attacks, although their benefit may be limited due to scarce availability and ageing.  The...

2011-10-12 09:20:00

LAS VEGAS, Oct. 12, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that its Board of Directors will conduct a process to explore and evaluate strategic alternatives for Cord Blood America to enhance shareholder value. Cord Blood America has not set a timetable...

2011-10-03 08:17:00

NEW YORK, Oct. 3, 2011 /PRNewswire/ -- Americord Registry, a leader in the advancement of cord blood and placenta stem cell preservation, has launched a reimbursement program for parents of children diagnosed with cerebral palsy and other acquired neurological conditions, such as perinatal asphyxia or brain damage, caused by oxygen deprivation during birth. (Logo: http://photos.prnewswire.com/prnh/20110209/NY44693LOGO ) Americord will reimburse the full cost of cord blood processing and...

2011-09-29 22:43:44

A $12 million, five-year grant from the National Cancer Institute will help researchers from The University of Texas MD Anderson Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and The Methodist Hospital improve outcomes of cord blood transplantation in children and adults with cancer. The collaboration brings together a team with research experience in cancer immunology, viral immunology, cord blood transplantation, adoptive...

2011-09-27 04:02:00

LAS VEGAS and BUENOS AIRES, Argentina, Sept. 27, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today updated shareholders on the progress of Biocordcell Argentina S.A. (BioCells, Inc.), which is 50.1 percent owned by Cord Blood America. "January through August revenues in...

2011-09-19 04:05:00

LAS VEGAS, Sept. 19, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it has received all State licenses and Federal registrations required to operate as a cord blood bank in the United States. These licenses include licenses from the State of New...